Patent · US Active

Immunogenic WT-1 peptides and methods of use thereof

US11859015B2 · kind B2 · utility

0Cited by
57References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 31, 2020
Grant dateJan 2, 2024
Priority date—
Expiry dateJun 8, 2042

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides peptides, immunogenic compositions and vaccines, and methods of treating, reducing the incidence of, and inducing immune responses to a WT1-expressing cancer, comprising heteroclitic peptides derived from the WT-1 protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.